Cargando…

PD-L1 expression in regional lymph nodes and predictable roles in anti-cancer immune responses

Detalles Bibliográficos
Autores principales:	Komohara, Yoshihiro, Harada, Mamoru, Ohnishi, Koji, Kumamoto, Keiichiro, Nakayama, Toshiyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JSLRT 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596915/ https://www.ncbi.nlm.nih.gov/pubmed/32641599 http://dx.doi.org/10.3960/jslrt.20015

Ejemplares similares

CD169 Expression on Lymph Node Macrophages Predicts in Patients With Gastric Cancer
por: Kumamoto, Keiichiro, et al.
Publicado: (2021)

Possible functions of CD169‐positive sinus macrophages in lymph nodes in anti‐tumor immune responses
por: Komohara, Yoshihiro, et al.
Publicado: (2017)

CD169 (+) sinus macrophages in regional lymph nodes do not predict mismatch‐repair status of patients with colorectal cancer
por: Saito, Yoichi, et al.
Publicado: (2023)

Potential mechanisms of spontaneous regression in patients with B-cell lymphoma; the significance of co-stimulatory molecules in lymphoma cells
por: Komohara, Yoshihiro, et al.
Publicado: (2019)

The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer
por: Shiota, Takuya, et al.
Publicado: (2016)

Prognostic significance of CD169‐positive lymph node sinus macrophages in patients with endometrial carcinoma
por: Ohnishi, Koji, et al.
Publicado: (2016)

CD169‐positive sinus macrophages in the lymph nodes determine bladder cancer prognosis
por: Asano, Touko, et al.
Publicado: (2018)

Naringenin potentiates anti-tumor immunity against oral cancer by inducing lymph node CD169-positive macrophage activation and cytotoxic T cell infiltration
por: Kawaguchi, Sho, et al.
Publicado: (2022)

Maf expression in human macrophages and lymph node sinus macrophages in patients with esophageal cancer
por: Takeya, Hiroto, et al.
Publicado: (2019)

Accurate expression of PD‐L1/L2 in lung adenocarcinoma cells: A retrospective study by double immunohistochemistry
por: Shinchi, Yusuke, et al.
Publicado: (2019)

Myeloid sarcoma incidentally found in lymph nodes dissected for advanced gastric cancer
por: Yamada, Rin, et al.
Publicado: (2023)

PD-L1 expression in papillary renal cell carcinoma
por: Motoshima, Takanobu, et al.
Publicado: (2017)

Lymph node density as a surrogate marker for positive lymph nodes
por: Van Gorp, T, et al.
Publicado: (2011)

Contrasting effects of cyclophosphamide on anti‐CTL‐associated protein 4 blockade therapy in two mouse tumor models
por: Iida, Yuichi, et al.
Publicado: (2017)

Different pathologic responses to neoadjuvant anti-PD-1 in primary squamous lung cancer and regional lymph nodes
por: Ling, Yun, et al.
Publicado: (2020)

Reply: Lymph node density as a surrogate marker for positive lymph nodes
por: Polterauer, S, et al.
Publicado: (2011)

Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection
por: Eroglu, Zeynep, et al.
Publicado: (2022)

TNM classification: clarification of number of regional lymph nodes for pN0
Publicado: (2001)

Strain elastography and lymph nodes
por: Çildağ, Mehmet B.
Publicado: (2019)

An IL‐27/Stat3 axis induces expression of programmed cell death 1 ligands (PD‐L1/2) on infiltrating macrophages in lymphoma
por: Horlad, Hasita, et al.
Publicado: (2016)

Pre-operative Evaluation of Lateral Pelvic Lymph Node Metastasis in Lower Rectal Cancer: Comparison of Three Different Imaging Modalities
por: Amano, Kunihiko, et al.
Publicado: (2020)

Simultaneous Dual Pathology in Lymph Node
por: Mandal, Prakas Kumar, et al.
Publicado: (2014)

Prognostic and clinical impact of PD-L2 and PD-L1 expression in a cohort of 437 oesophageal cancers
por: Okadome, Kazuo, et al.
Publicado: (2020)

Sentinel Lymph Node Biopsy and Complete Lymph Node Dissection for Melanoma
por: Falk Delgado, Alberto, et al.
Publicado: (2019)

PD-1 Expression by Lymph Node and Intratumoral Regulatory T Cells Is Associated with Lymph Node Metastasis in Pancreatic Cancer
por: Seifert, Adrian M., et al.
Publicado: (2020)

Generalized lymph node immunoglobulin G amyloidoma
por: Chan, Tao, et al.
Publicado: (2012)

Cytokine production in mammary adenocarcinoma and its microenvironmental cells in patients with or without metastases in regional lymph nodes
por: Autenshlyus, Alexander, et al.
Publicado: (2017)

The global landscape of neoadjuvant and adjuvant anti-PD-1/PD-L1 clinical trials
por: Wu, Dawei, et al.
Publicado: (2022)

Reply to ‘Addressing the challenge of proper delineation of lymph node stations in modern radiotherapy for lung cancer’
por: Tamaki, Yukihisa, et al.
Publicado: (2018)

PD-L1 Expression Is an Independent Marker for Lymph Node Metastasis in Middle Eastern Endometrial Cancer
por: Siraj, Abdul K., et al.
Publicado: (2021)

Mathematical Modeling Reveals That the Administration of EGF Can Promote the Elimination of Lymph Node Metastases by PD-1/PD-L1 Blockade
por: Benchaib, Mohamed Amine, et al.
Publicado: (2019)

Expression of PD-1/PD-L1 in primary breast tumours and metastatic axillary lymph nodes and its correlation with clinicopathological parameters
por: Yuan, Chenxi, et al.
Publicado: (2019)

Improvement of NMDA encephalitis by active lymph node removal
por: Iwamoto, Tatsushige, et al.
Publicado: (2013)

Dedifferentiated Endometrial Carcinoma Could be A Target for Immune Checkpoint Inhibitors (Anti PD-1/PD-L1 Antibodies)
por: Ono, Ruriko, et al.
Publicado: (2019)

Local injection of CCL19-expressing mesenchymal stem cells augments the therapeutic efficacy of anti-PD-L1 antibody by promoting infiltration of immune cells
por: Iida, Yuichi, et al.
Publicado: (2020)

Enhancing anti-tumor immunity through local gene delivery to lymph nodes
por: Dold, Neil M, et al.
Publicado: (2015)

Programming the lymph node microenvironment to enhance anti-tumor T cell immunity in neuroblastoma
por: Gammon, Joshua M, et al.
Publicado: (2015)

PD-L1(+) lung cancer stem cells modify the metastatic lymph-node immunomicroenvironment in nsclc patients
por: Raniszewska, A., et al.
Publicado: (2020)

Mesenchymal stem cells empower T cells in the lymph nodes via MCP-1/PD-L1 axis
por: He, Yifan, et al.
Publicado: (2022)

Efficacy of PET/CT in diagnosis of regional lymph node metastases in patients with colorectal cancer: retrospective cohort study
por: Yukimoto, Ryohei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aamefjjvj34uboau49iq6s5e2u